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Abstract: Radiofrequency ablation (RFA) is a standard
clinical procedure for treating many cardiac arrhythmias.
In order to increase the success rate of this treatment, the
evaluation of lesiondevelopmentwith thehelp of intracar-
diac electrogram (EGM) criteria has to be improved further.
We are investigating in-vitro the electrophysiological char-
acteristics of cardiac tissue by using fluorescence-optical
and electrical techniques. In this project, it is intended
to create ablation lesions under defined conditions in rat
atria or ventricle and to determine the electrical activity
in the myocardium surrounding these lesions less than
1 s after the ablation. Therefore, we developed a semi-
automatic RFA procedure, which was integrated into an
existing experimental setup. Firstly, a controllable protec-
tion circuit board was designed to galvanically isolate the
sensitive amplifiers for measuring extracellular potentials
during the ablation. Secondly, a real-time system was im-
plemented to control and to autonomously monitor the
RFA procedure. We verified each component as well as the
different sequences of the RFA procedure. In conclusion,
the expanded setup will be used in future in-vitro exper-
iments to determine new EGM criteria to assess lesion
formation during the RFA procedure.
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1 Introduction
Atrial fibrillation is one of the most frequent cardiac ar-
rhthymias in the western world and radiofrequency ab-
lation is a standard clinical procedure for treating this
arrhythmia. According to Shurrab et al., the reccurence
rate of an arrhythmia is around 35–40 [1]. In order to
increase the success rate, a specific knowledge about the
transmurality as well as the geometry of an ablation le-
sion is necessary. To date, several control methods ex-
ist to evaluate lesion formation, such as late gadolinium
magnetic resonance imaging [2] or ultrasound [3]. Un-
fortunately, none of these methods offer robust criteria
to assess ablation lesions. In-vitro experiments allow a
unique chance to investigate cardiac electrophysiology
of vital myocardium under controlled conditions. Thia-
galingam et al. used a force-sensing catheter to evaluate
the importance of catheter contact force in a porcine ex-
vivo model [4]. Moreover, Otomo et al. investigated the
(EGM)-based criteria to assess single point ablation le-
sions in a porcinemodel and demonstrated a high relation
between changes of intracardiac EGMs and lesion trans-
murality [5]. However, the observational design of this
study was limited. Therefore, further studies are required
to determine the changes of EGMs due to lesion develop-
ment under defined conditions. We established an in-vitro
setup to measure the electrophysiological characteristics
of rat myocardium by using simultaneously fluorescence-
optical mapping and electrical techniques. In this study,
we present the integration of a semi-automatic RFA proce-
dure into the in-vitro setup. Therefore, it will be feasible
to create ablation lesions and to determine the electri-




All animal experiments were approved by the local com-
mittee for animal welfare (35-9185.81/G-61/12). For defined
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measurment conditions, the rat myocardium is positioned
in a tissue bath with heated Krebs-Henseleit solution,
which allows the nutrition and oxygenation of the prepa-
ration for several hours. Fluorescence-optical mapping is
performed from the bottom side of the tissue bath by using
a voltage-sensitive dye (di-4-ANEPPS). A self-developed
multielectrode array is used to measure the extracellular
potentials of rat myocardium surrounding the acute ab-
lation lesion. The electrical recordings are digitized with
a data acquisition system from National Instruments and
are analyzed by a custom written software in MATLAB 8.1
(The MathWorks Inc., Natick, MA, USA). For the in-vitro
RFA procedure, we are using the electrosurgical unit MD1
(Micromed, Wurmlingen, Germany) with low power set-
tings as well as manual control by a foot switch. The
ablation electrode (diameter of 0.3mm) is placed perpen-
dicular onto the surface of themyocardium to create punc-
tiform ablation lesions. We developed a controllable pro-
tection circuit board (CPCB) to ensure that no residual cur-
rents from the ablation electrodewill damage the sensitive
measurement equipment during the ablation. Moreover,
the electrosurgical unit as well as the CPCB are controlled
by a real-time system. This monitors the reproducible RFA
procedure, which consists of three different sequences. In
a first step, the measurement electrodes have to be dis-
connected safely from the amplifier system. Secondly, the
electrosurgical unit is switched on by the real-time system
to create lesions with fixed times and power settings. In
a last step, the measurement electrodes are reconnected
with the amplifier system tomeasure the electrical activity
after the RFAprocedurewithout a large time delay. Figure 1
shows the relationship between each component and their
functional relation, which are explained in detail in the
following sections.
2.2 Controllable protection circuit board
The self-developed CPCB represents a main component of
the in-vitro RFA procedure and has to fulfill the follow-
ing requirements: high electrical isolation, fast switching
rates, and small (negligible) influence on signal quality.
Therefore, we used the electromechanical relay IM26GR
(Axicom, Germany) to ensure the galvanic separation
of each measurement channel (surge capability up to
2500Vrms between open contacts). The switching opera-
tion of the relays is controlled by an external TTL signal
with switching times less than 5ms. In order to minimize
electrical interference during the sensitive measurement
phase, the relays are only active in the second sequence























Figure 1: Overview of the components and their functional
relationship for the in-vitro RFA procedure.
monitors the switching state of each relay by using a mon-
itoring voltage. After the successful switching of all relays
(monitoring voltage grounded) the RFA procedure will be
continued. The electrical components are powered by an
external battery to reduce powerline noise.
2.3 Control board
The main component of the CB is the microcontroller
ATxmega128A1U (Atmel Corporation, San Jose, CA, USA),
which controls the different sequences during the RFA
procedure and monitors the state of the CPCB as well as
of the electrosurgical unit. We configured the controller
with a self-developed C-program to ensure real-time be-
havior and to process user input. Before the RFA pro-
cedure, the microcontroller is programmed by a custom
written software in MATLAB 8.1. Hereby, the user will
specify the switching times of the relays and the ablation
time. Furthermore, we used two controllable relays KT12-
1A-40L (Meder, Germany) to connect the electrosurgical
unit and the ablation electrode during the ablation pro-
cess. This will reduce additional interfering signals on the
ablation electrode during the measurement phase. After
the successful configuration of themicrocontroller and the
manual start of the RFA procedure, the CB switches the
relays on the CPCB. Afterwards, the relays on the CB are
switched on and the electrosurgical unit is activated for a
definedablation time. In the last phase, the electrosurgical
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unit is switched off, the relays of the CB aswell as the CPCB
are reset and the electrical measurement is started.
2.4 Signal acquisition
For data acquisition, we used two portable 4-channel pre-
cision measurement systems, which were developed at
the Institute of Biophysics of the Medical University of
Graz. The acquired signals are amplified by a factor of 100
and filtered with an active 4th-order Bessel antialiasing
filter (cutoff frequency: 20 kHz). The signals are simultane-
ously digitizedwith 100 ksps and 16-bit resolution (NI9215,
National InstrumentsGermanyGmbH,Munich,Germany).
2.5 Test phase
The above-mentioned components had to be integrated
into the experimental setup. In this test phase, the com-
plete RFA procedure and the interaction between the dif-
ferent components were examined carefully. For this pur-
pose, conductive saline solutionwas used instead of living
rat myocardium. We placed the multielectrode array, the
ablation electrode, and a stimulus electrode in the tissue
bath, which was filled with saline solution. A rectangular
shaped current pulse with a duration of 1ms was gener-
ated by a constant current stimulus isolator A365 (World
Precision Instruments, Sarasota, FL, USA) to simulate the
electrical activity of myocardium. The output power of the
electrosurgical unit was set to 2W. Noise power Pnoise of








wheren are the samples of the considered interval of noise,
fs is the sample rate (100 kHz), u(n) is the signal, and µu(n)
is the mean value of the signal u(n).
3 Results
A complete RFA procedure with the different switching
states of the relays on the CPCB, the ablation process and
the electrical measurements are shown in Figure 2. The
switching of the relays caused some ripple and two clear
peaks in the measured signals. The stimuli started around
2 s after the ablation. Figure 3 shows the second sequence
of the RFA procedure before the ablation. After the suc-
cessful switching of the relays (active high), the switching
signal of the electrosurgical unit was set (active low). The
CB detected the switching of the relays via the monitoring


























Figure 2: Electrical recording, switching signal for the relays
(Relay 1–6) on the CPCB (active low), and switching signal for
the electrosurgical unit (active high) during the complete RFA
procedure.






































Figure 3: Switching signals for the relays (Relay 1–6) on the CPCB
(active low) and for the electrosurgical unit (active high) at the
beginning of the ablation. Insets present the time delays after the
switching of the relays (around 1ms; left) and the electrosurgical
unit (around 5ms; right).
voltage (not shown in Figure 3) and high-frequency cur-
rent was supplied to the ablation electrode after a short
timedelay (around5ms). Interfering signalswere acquired
during the ablation, although the electrodes were sepa-
rated from the amplifier system. After the ablation, the
switching signal of each relay was reset (see Figure 4). The
delay of the electrosurgical unit was around 3ms. Figure 5
presents the recorded stimulus signal after the ablation.
According to equation (1), the noise power was calculated
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Figure 4: Switching signals for the (Relay 1–6) on the CPCB (active
low), and switching signal for the electrosurgical unit (active high)
at the end of the ablation. The time delay of the electrosurgical unit
was around 3ms.



























Figure 5:Measured stimulus signal of the stimulus generator. Inset
illustrates the signal noise used for noise calculations.
to 0.0391 V2, which amounted in a signal-to-noise ratio
(SNR) of 65.47 (18.16 dB).
4 Discussion
We developed a semi-automatic RFA procedure to create
ablation lesions on living myocardium. For this purpose,
a configurable real-time system controls and monitors in-
dependently the RFA procedure. In the test phase, the
individual sequences of the RFA procedure were validated
successfully. The sequential switching and the switching
times of the relays as well as of the electrosurgical unit
were verified. The CPCB, which was based on electrome-
chanical relays, securely protected the sensitive amplifier
system. A maximum ablation power of 8W verified the
dielectric strength of the CPCB. Additionally, we included
a safety delay (waiting time) of 15ms after the ablation to
ensure the guaranteed switching of the electromechanical
relays. Short-term ripples as well as sharp peaks occurred
in the acquired signal due to switching processes of the
relays. However, these irregularities are within the con-
figurable waiting times and will not influence the sub-
sequent electrical measurements. The determined SNR
demonstrated that the CPCB did not strongly increase in-
terfering signals. The irrectangular shape of the measured
stimulus signal was probably caused by capacitive effects
of the Ag/AgCl electrodes. The delay between the activa-
tion of the MD1 by the CB and the effective start of the
ablation could be induced by an internal response time
of the electrosurgical unit. A similar time delay was seen
when this device was switched off. Therefore, it has to
be regarded for further measurements that the relays of
the CPCB should not switch during this time period. The
safety requirements of the whole setup were also tested.
Therefore, we investigated the failure behavior of the real-
time system, which was less than 1ms, as well as the
clear separation between the ablation electrode and the
electrosurgical unit during the active state of the relays.
In conclusion, the presented in-vitroRFA procedure allows
the creation of acute ablation lesions with varying geome-
try and transmurality under reproducible conditions. Fur-
thermore, it is feasible to determine electrophysiological
changes of myocardium surrounding the ablation lesion
after approximately 20ms.
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